Moody’s Ratings Upgrades Teva to Investment Grade, Reflecting the Ongoing Execution of Pivot to Growth Strategy
Moody's Ratings has upgraded Teva Pharmaceutical Industries Ltd.'s corporate credit rating to Baa3 (investment grade) from Ba1, with a stable outlook. This upgrade reflects the success of Teva's "Pivot to Growth" strategy, including innovative products, an expanded pipeline, and continued debt reduction. The company's …